BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mombelli M, Rettby N, Perreau M, Pascual M, Pantaleo G, Manuel O. Immunogenicity and safety of double versus standard dose of the seasonal influenza vaccine in solid-organ transplant recipients: A randomized controlled trial. Vaccine. 2018;36:6163-6169. [PMID: 30181045 DOI: 10.1016/j.vaccine.2018.08.057] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Mombelli M, Hoschler K, Cavassini M, Pascual M, Manuel O. Seasonal trivalent inactivated influenza vaccine with topical imiquimod in immunocompromised patients: A randomized controlled trial. J Infect 2021;83:354-60. [PMID: 34298035 DOI: 10.1016/j.jinf.2021.07.010] [Reference Citation Analysis]
2 Manuel O. COVID-19 vaccination in solid-organ transplant recipients: generating new data as fast as possible, but taking clinical decisions as slow as necessary. Clin Microbiol Infect 2021;27:1070-1. [PMID: 34153456 DOI: 10.1016/j.cmi.2021.06.018] [Reference Citation Analysis]
3 Narasimhan M, Mahimainathan L, Clark AE, Usmani A, Cao J, Araj E, Torres F, Sarode R, Kaza V, Lacelle C, Muthukumar A. Serological Response in Lung Transplant Recipients after Two Doses of SARS-CoV-2 mRNA Vaccines. Vaccines (Basel) 2021;9:708. [PMID: 34208884 DOI: 10.3390/vaccines9070708] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Charmetant X, Espi M, Benotmane I, Barateau V, Heibel F, Buron F, Gautier-Vargas G, Delafosse M, Perrin P, Koenig A, Cognard N, Levi C, Gallais F, Manière L, Rossolillo P, Soulier E, Pierre F, Ovize A, Morelon E, Defrance T, Fafi-Kremer S, Caillard S, Thaunat O. Infection or a third dose of mRNA vaccine elicit neutralizing antibody responses against SARS-CoV-2 in kidney transplant recipients. Sci Transl Med 2022;:eabl6141. [PMID: 35103481 DOI: 10.1126/scitranslmed.abl6141] [Reference Citation Analysis]
5 Filippidis P, Vionnet J, Manuel O, Mombelli M. Prevention of viral infections in solid organ transplant recipients in the era of COVID-19: a narrative review. Expert Rev Anti Infect Ther 2021;:1-18. [PMID: 34854329 DOI: 10.1080/14787210.2022.2013808] [Reference Citation Analysis]
6 Arora S, Kipp G, Bhanot N, Sureshkumar KK. Vaccinations in kidney transplant recipients: Clearing the muddy waters. World J Transplantation 2019; 9(1): 1-13 [PMID: 30697516 DOI: 10.5500/wjt.v9.i1.1] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 6] [Article Influence: 3.7] [Reference Citation Analysis]
7 Lai JJ, Lin C, Ho CL, Chen PH, Lee CH. Alternative-Dose versus Standard-Dose Trivalent Influenza Vaccines for Immunocompromised Patients: A Meta-Analysis of Randomised Control Trials. J Clin Med 2019;8:E590. [PMID: 31035712 DOI: 10.3390/jcm8050590] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 D'Offizi G, Agrati C, Visco-Comandini U, Castilletti C, Puro V, Piccolo P, Montalbano M, Meschi S, Tartaglia E, Sorace C, Leone S, Lapa D, Grassi G, Goletti D, Ippolito G, Vaia F, Ettorre GM, Lionetti R. Coordinated cellular and humoral immune responses after two-dose SARS-CoV2 mRNA vaccination in liver transplant recipients. Liver Int 2021. [PMID: 34719107 DOI: 10.1111/liv.15089] [Reference Citation Analysis]
9 Scemla A, Manda V. Infectious complications after kidney transplantation. Nephrol Ther 2019;15 Suppl 1:S37-42. [PMID: 30981394 DOI: 10.1016/j.nephro.2019.03.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Holden IK, Bistrup C, Nilsson AC, Hansen JF, Abazi R, Davidsen JR, Poulsen MK, Lindvig SO, Justesen US, Johansen IS. Immunogenicity of SARS-CoV-2 mRNA vaccine in solid organ transplant recipients. J Intern Med 2021. [PMID: 34237179 DOI: 10.1111/joim.13361] [Reference Citation Analysis]
11 Chang YT, Ling TC, Cheng YY, Sun CY, Wu JL, Tai CH, Wang JR, Sung JM. Comparison of Immunogenicity and Safety between a Single Dose and One Booster Trivalent Inactivated Influenza Vaccination in Patients with Chronic Kidney Disease: A 20-Week, Open-Label Trial. Vaccines (Basel) 2021;9:192. [PMID: 33669067 DOI: 10.3390/vaccines9030192] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
12 [DOI: 10.1101/2021.04.26.21255926] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Haddadin Z, Krueger K, Thomas LD, Overton ET, Ison M, Halasa N. Alternative strategies of posttransplant influenza vaccination in adult solid organ transplant recipients. Am J Transplant 2021;21:938-49. [PMID: 32885604 DOI: 10.1111/ajt.16295] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 9.5] [Reference Citation Analysis]
14 Hwang JH, Oh MR, Hwang JH, Choi EK, Jung SJ, Song EJ, Españo E, Webby RJ, Webster RG, Kim JK, Chae SW. Effect of processed aloe vera gel on immunogenicity in inactivated quadrivalent influenza vaccine and upper respiratory tract infection in healthy adults: A randomized double-blind placebo-controlled trial. Phytomedicine 2021;91:153668. [PMID: 34385093 DOI: 10.1016/j.phymed.2021.153668] [Reference Citation Analysis]
15 Colmegna I, Useche ML, Rodriguez K, Mccormack D, Alfonso G, Patel A, Ramanakumar AV, Rahme E, Bernatsky S, Hudson M, Ward BJ. Immunogenicity and safety of high-dose versus standard-dose inactivated influenza vaccine in rheumatoid arthritis patients: a randomised, double-blind, active-comparator trial. The Lancet Rheumatology 2020;2:e14-23. [DOI: 10.1016/s2665-9913(19)30094-3] [Cited by in Crossref: 9] [Article Influence: 4.5] [Reference Citation Analysis]
16 Giannella M, Pierrotti LC, Helanterä I, Manuel O. SARS-CoV-2 vaccination in solid-organ transplant recipients: What the clinician needs to know. Transpl Int 2021;34:1776-88. [PMID: 34450686 DOI: 10.1111/tri.14029] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Valour F, Conrad A, Ader F, Launay O. Vaccination in adult liver transplantation candidates and recipients. Clin Res Hepatol Gastroenterol. 2020;44:126-134. [PMID: 31607643 DOI: 10.1016/j.clinre.2019.08.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
18 Yi SG, Moore LW, Eagar T, Graviss EA, Nguyen DT, Ibrahim H, Huang HJ, Hobeika M, McMillan R, Saharia A, Mobley C, Podder H, Drews A, Ghobrial RM, Gaber AO, Knight RJ. Risk Factors Associated With an Impaired Antibody Response in Kidney Transplant Recipients Following 2 Doses of the SARS-CoV-2 mRNA Vaccine. Transplant Direct 2022;8:e1257. [PMID: 34912946 DOI: 10.1097/TXD.0000000000001257] [Reference Citation Analysis]
19 Mombelli M, Kampouri E, Manuel O. Influenza in solid organ transplant recipients: epidemiology, management, and outcomes. Expert Review of Anti-infective Therapy 2020;18:103-12. [DOI: 10.1080/14787210.2020.1713098] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
20 de St Maurice A, Halasa N. Preparing for the 2019-2020 influenza season. Pediatr Transplant 2020;24:e13645. [PMID: 31885157 DOI: 10.1111/petr.13645] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]